(Press-News.org) Highlights
Patients who received dexamethasone during heart surgery had about a 2.5-times lower risk of developing kidney failure requiring dialysis compared with those receiving a placebo.
The greatest benefits of dexamethasone were seen in patients with pre-existing advanced chronic kidney disease.
Acute kidney injury can be a serious complication following heart surgery.
Washington, DC (May 7, 2015) -- The anti-inflammatory drug dexamethasone helps prevent serious kidney complications that can arise following heart surgery, according to the results of a randomized clinical trial. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), could lead to a change in care for patients during cardiac operations.
Acute kidney injury (AKI) is one of the most devastating complications following cardiac surgery. Approximately 1% of patients undergoing cardiac surgery require dialysis to treat severe AKI that arises after surgery, and the incidence is higher among patients with pre-operative chronic kidney disease. These patients experience strikingly high death rates while in the hospital that exceed 40%. "One percent sounds like a small percentage, however given the fact that each year, over half a million people undergo heart surgery in the United States alone, this means that an estimated 5000 patients develop renal failure and of those about 2500 die as a result of this complication," said Kirolos Jacob, MD (University Medical Center, Utrecht, The Netherlands). He noted that these figures are rising due to the aging population.
Because heart surgery initiates an inflammatory reaction in the body that can have negative effects on the kidneys, Dr. Jacob and his colleagues wondered whether giving patients dexamethasone, an anti-inflammatory drug, could decrease the risk of severe AKI following cardiac surgery. The team analyzed the results of a large randomized controlled trial called the Dutch Dexamethasone for Cardiac Surgery (DECS) trial, which included 4465 patients undergoing cardiac surgery who were randomized to receive placebo or dexamethasone during surgery. The original trial tested whether dexamethasone could reduce the risk of a variety of major postoperative complications. In this analysis, the investigators specifically examined kidney failure and focused on the most severe form: AKI requiring dialysis.
Dexamethasone appeared to protect against the development of severe AKI. Patients who received the drug had about a 2.5-times lower risk of developing AKI requiring dialysis compared with those receiving a placebo.
"The beneficial effects of dexamethasone were particularly present in those who already had pre-existing kidney disease before heart surgery," said Dr. Jacob. "This reinforces the fact that this drug could be of major importance for the increasing elderly population with pre-existing kidney disease undergoing a heart operation."
The study is the largest randomized, placebo-controlled trial showing a potential benefit of any therapeutic drug for the prevention of severe kidney injury following heart surgery. A single dose of dexamethasone during a heart operation is inexpensive, straightforward, painless, and safe for patients. "These advantages make the intervention very accessible and cost-effective, especially since the costs for dialysis are very high," said Dr. Jacob.
INFORMATION:
Study co-authors include David Leaf, MD, MMSc, Jan Dieleman, MD, Diederik van Dijk, MD, PhD, Arno Nierich, MD, PhD, Peter Rosseel, MD, PhD, Joost van der Maaten, MD, PhD, Jan Hofland, MD, PhD, Jan Diephuis, MD, Fellery de Lange, MD, PhD, Christine Boer, PhD, Jolanda Kluin, MD, PhD, Sushrut Waikar, MD, MPH, for the Dexamethasone for Cardiac Surgery (DECS) Study Group.
Disclosures: The DECS study was sponsored by grants from the Netherlands Organisation for Health Research and Development (ZonMw) and the Dutch Heart Foundation.
The article, entitled "Intraoperative High-Dose Dexamethasone and Severe Acute Kidney Injury after Cardiac Surgery," will appear online at http://jasn.asnjournals.org/ on May 7, 2015.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 15,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
Philadelphia, PA, May 7, 2015 - Current U.S. health policy requires Medicaid beneficiaries to wait 30 days before tubal sterilization. Ob/gyn experts argue that this violates health care justice as elective tubal sterilization is readily available to women with a private source of payment. Writing in the American Journal of Obstetrics & Gynecology, they urge obstetricians to advocate for change to eliminate health care injustice in women's access to elective tubal sterilization.
One of the most common forms of contraception in the U.S. is tubal sterilization after childbirth, ...
San Francisco, May 7, 2015 - Detailed gait analysis reveals that people with clogged leg arteries rely more on muscles in the back of the calf when they walk to compensate for weakness in certain hip muscles, according to a new study presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions 2015.
This suggests that exercise training to strengthen hip flexor muscles may increase how far patients can walk without calf pain.
Peripheral artery disease (PAD) is a narrowing of the arteries ...
A group of leading soil scientists, including the University of Delaware's Donald L. Sparks, has summarized the precarious state of the world's soil resources and the possible ramifications for human security in a paper published Thursday, May 7, in the journal Science.
In a review of recent scientific literature, the article, titled "Soil and Human Security in the 21st Century," outlines threats to soil productivity -- and, in turn, food production -- due to soil erosion, nutrient exhaustion, urbanization and climate change.
"Soil is our planet's epidermis," said Sparks, ...
Crigler-Najjar syndrome is a rare autosomal recessive disorder caused by mutations in the UGT1A1 gene, which result in the toxic accumulation of bilirubin, a substance made by the liver in the body. Indeed, when the UDP-glucuronosyltransferase 1 isotype A1 (UGT1A1), the enzyme responsible for removing bilirubin, doesn't work, the substance accumulates, causing a severe and chronic jaundice, and becoming toxic for the brain and leading to lethality.
Gene therapy has allowed the restoration of an equivalent level of bilirubin to those found in healthy animals
Federico ...
Luring longtime and new customers to try online shopping, and retaining them in a competitive and crowded marketplace, is the challenge of the day for established offline retailers. A study of the multichannel UK grocery shopping environment recently yielded insights that will be useful for retailers with an online channel or considering adding one to their customers' options.
A team of researchers from Belgium's KU Leuven (University of Leuven), led by doctoral candidate Kristina Melis, investigated purchasing behavior and the adoption of an online grocery shopping ...
Researchers at the University of Illinois at Chicago have determined the molecular structure of one of the proteins in the fine fibers of the brain plaques that are a hallmark of Alzheimer's disease. This molecule, called amyloid beta-42, is toxic to nerve cells and is believed to provoke the disease cascade.
The study is online in the journal Nature Structural and Molecular Biology.
Knowing the physical structure of the 42 amino acid-long form of amyloid beta in the fibers is key to understanding how it folds up improperly and aggregates into toxic plaques, says Yoshitaka ...
This news release is available in Spanish. (SACRAMENTO, Calif.) -- Researchers at UC Davis have developed a new intervention that identifies potentially depressed mothers and encourages them to seek treatment. The Motivating our Mothers (MOM) program takes a unique approach, relying on pediatricians rather than the mother's doctor for diagnosis. In the study, mothers were given a short survey to assess whether they needed additional care. Those who identified depression symptoms were then coached by a research assistant to seek further help.
The program had a remarkable ...
A new study shows that it is possible to use an imaging technique called cryo-electron microscopy (cryo-EM) to view, in near-atomic detail, the architecture of a metabolic enzyme bound to a drug that blocks its activity. This advance provides a new path for solving molecular structures that may revolutionize drug development, noted the researchers.
The protein imaged in this study was a small bacterial enzyme called beta-galactosidase; the drug to which it was bound is an inhibitor called phenylethyl-beta-D-thiogalactopyranoside (PETG), which fits into a pocket in the ...
Messenger RNA (mRNA) levels dictate most differences protein levels in fast-growing cells when analyzed using statistical methods that account for noise in the data, according to a new study by researchers from the University of Chicago and Harvard University.
The research, published May 7, 2015 in the journal PLOS Genetics, counters widely reported studies arguing that the correlation between mRNA transcript levels and protein levels is relatively low, and that processes acting after mRNA transcription override mRNA levels. Instead, the authors argue, these conclusions ...
Boston, MA -- Researchers at Harvard T. H. Chan School of Public Health and the Broad Institute have identified a protein on the surface of human red blood cells that serves as an essential entry point for invasion by the malaria parasite. The presence of this protein, called CD55, was found to be critical to the Plasmodium falciparum parasite's ability to attach itself to the red blood cell surface during invasion. This discovery opens up a promising new avenue for the development of therapies to treat and prevent malaria.
"Plasmodium falciparum malaria parasites have ...
